Takeda Pharmaceuticals USA Reports Data Breach to New Hampshire AG

Takeda Pharmaceuticals USA, Inc. submitted a data breach notification to the New Hampshire Attorney General's office on May 29, 2026. This filing acknowledges an incident where personal information may have been exposed, though specific details regarding the breach type were not provided in the public record.

The official filing does not specify the exact categories of personal information involved, nor does it state the number of individuals affected. Furthermore, the precise date when the breach occurred remains undisclosed, with the company indicating that an investigation is currently underway.

Individuals who have a relationship with Takeda Pharmaceuticals USA, Inc. and are concerned about their personal data should remain vigilant. It is always prudent to monitor account statements and credit reports for any suspicious activity and be cautious of unsolicited communications requesting personal details.

This information is derived directly from the public filing submitted to state regulators. The company's notification indicates that the situation is actively being investigated to understand the full scope and impact of the reported incident.